Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 53
- Policy & Regulation
Ireland’s Cannabis Reform Gains Momentum: Oireachtas Committee Pushes Decriminalisation of Cannabis in Ireland
The Oireachtas Joint Committee on Drugs Use has published its interim report into the recommendations of Ireland’s landmark Citizens’ Assembly on Drugs Use, coming out strongly in favour of decriminalisation.
- Press releases
NHS Failing to Provide Medical Cannabis for Patients in Need, Says CIC
The NHS is failing to prescribe cannabis flower medication to any patients, including those with conditions such as epilepsy, chronic pain, and cancer, according to new research from the Cannabis Industry Council (CIC).
- Uncategorized
Top Cannabis Investors Gather at Business of Cannabis: New York – Offering Direct Access to Funding for NYC Entrepreneurs
New York’s cannabis entrepreneurs have a unique opportunity this November to connect directly with Sergey Sherman and the team at Tuatara Capital, administrators of the Cannabis NYC Loan Fund
- Uncategorized
DEA Begins Selecting Witnesses Ahead of Critical Cannabis Rescheduling Trial
The US Drug Enforcement Administration (DEA) has announced the first witnesses due to attend the critical upcoming public hearing on cannabis rescheduling.
- Markets & Stocks
Flora Growth Significantly Expands European Foothold, Akanda Sees Spike in Revenues, & More From Argent Biopharma
Akanda Corp [stock_market_widget type=”chart” template=”line” assets=”AKAN” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] NASDAQ-listed international medical cannabis operator Akanda Corp has seen its stock drop by double digits this week amid the release of its half-year results.
- Data & Analysis
European Medical Cannabis Boom Driven by Telemedicine and Regulatory Reforms
Telemedicine technology is driving rapid expansion of medical cannabis markets across Europe, according to Prohibition Partners’ upcoming Global Cannabis Report: 5th Edition.
- Uncategorized
New York’s Unlicensed Cannabis Store Crackdown Ruled Unconstitutional in Major Blow for Legal Operators
In a major setback for New York’s legal cannabis businesses, a state judge has ruled that recently supercharged efforts to close illicit stores are ‘unconstitutional’.
- Hemp Industry
EU to Investigate Italy’s Hemp Crackdown as Italian Courts and Industry Stakeholders Mount Opposition
The Italian hemp industry is continuing to battle attempted government crackdowns on two separate fronts.
- Uncategorized
New York’s Legal Cannabis Market Now ‘Ready to Hit Its Stride’
New York’s legal cannabis market is now ‘ready to hit its stride’ as initially intended following a turbulent entrance into the US adult-use market.
- Opinion
Colombia Emerging as a Global Supplier of Cannabis
Major exporters of medical cannabis, such as Colombia, are in a position to become early market leaders by complying with the regulations of nations that currently rely on international imports due to limited or no domestic production capabilities.
- Uncategorized
Hemp Business Owners Sue Texas Authorities, Claim Violations in Allen Store Raids
The Hemp Industry Leaders of Texas (HILT), alongside business owner Sabihe Kahn, have filed a federal lawsuit challenging the constitutionality of a series of police raids on hemp businesses in Allen, Texas.
- Uncategorized
Calls for Treasury to Update Tax Guidelines for Cannabis Businesses as Rescheduling Decision Looms
Ahead of the upcoming public hearing on cannabis rescheduling in the US, the American Institute of Certified Public Accountants (AICPA) has called on the Treasury Department to update tax guidelines for cannabis businesses.










